Trade Summary

6 days ago, KENNEY CHRISTOPHER JOHN, serving as Chief Medical Officer at Xenon Pharmaceuticals Inc. (XENE), sold 7,068 shares at $60.25 per share, for a total transaction value of $425,828.99. Following this transaction, KENNEY CHRISTOPHER JOHN now holds 2 shares of XENE.

This sale represents a 99.97% decrease in KENNEY CHRISTOPHER JOHN's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, August 28, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, September 1, 2026 (accepted Aug 31, 9:59 PM ET), 4 days after the trade was made.

Xenon Pharmaceuticals Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.